TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
CLEVELAND, Nov. 07, 2016 -- Chart Industries, Inc. (Nasdaq:GTLS), a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy and biomedical industries, today announced an organizational realignment within its BioMedical Group to better position the company to capture future growth in the respiratory products industry.
The Group will realign a portion of its manufacturing and engineering operations and establish a Respiratory Center-of-Excellence in Canton, GA where engineering, manufacturing, sales and marketing will be centralized to jointly develop and deliver industry leading respiratory products. To realize this change, the company expects to consolidate a majority of its U.S. respiratory operation and engineering activities into the existing Canton, GA campus, relocate key personnel, and suspend production and engineering of respiratory products at its Amherst, NY facility.
“This transformation enables the company to improve collaboration and infrastructure utilization to drive product innovation, efficiency, speed, and quality,” said Earl Lawson, President of Chart BioMedical. “This realignment and our continued investment in respiratory solutions demonstrates our commitment to the industry and to improving the quality of life for millions of people suffering from COPD and other lung diseases. We are positioning the company to meet our strategic goal to have associated core engineering, manufacturing, sales and marketing resources located together to better support the growing demand for our products.”
Chart is a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy, and biomedical industries. The majority of Chart's products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end-use applications. Chart has domestic operations located across the United States and an international presence in Asia, Australia, Europe and South America. For more information, visit: http://www.chartindustries.com.
Contact: Ken Webster Vice President and Chief Financial Officer 216-626-1216 [email protected]
